Proceedings of the National Academy of Sciences · 1996 · 363 citations · 25 references
Life SciencesMolecular BiologyNeuroscienceDevelopmental NeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeural DevelopmentNeurodegenerative DiseasesNeurodegenerative DisordersC. Elegans Developmental ModelsFunctional AssaysGain-of-function AnalysisGain-of-function EffectsGain-of-function ModelsPresenilin MutationsProteolysis Products
We provide evidence that normal human presenilins can substitute for Caenorhabditis elegans SEL-12 protein in functional assays in vivo. In addition, six familial Alzheimer disease-linked mutant human presenilins were tested and found to have reduced ability to rescue the sel-12 mutant phenotype, suggesting that they have lower than normal presenilin activity. A human presenilin 1 deletion variant that fails to be proteolytically processed and a mutant SEL-12 protein that lacks the C terminus display considerable activity in this assay, suggesting that neither presenilin proteolysis nor the C terminus is absolutely required for normal presenilin function. We also show that sel-12 is expressed in most neural and nonneural cell types in all developmental stages. The reduced activity of mutant presenilins and as yet unknown gain-of-function properties may be a contributing factor in the development of Alzheimer disease.
25
THE GENETICS OF <i>CAENORHABDITIS ELEGANS</i>
Sydney Brenner · Genetics · 1974 · 15.5K citations · Full text
Life Sciences, Biology, Genetics +14
Donalyn Scheuner, Christopher B. Eckman, M. Jensen et al. · Nature Medicine · 1996 · 2.6K citations